Back and face involvement in hidradenitis suppurativa

Dermatology

Volumn 221, Issue 2, 2010, Pages 137-141

  Poli, Florence ^a,b   Wolkenstein, Pierre ^a   Revuz, Jean ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b NONE

Author keywords

Acne; Acne conglobata; Acne inversa; Hidradenitis suppurativa

Indexed keywords

CLINDAMYCIN; ISOTRETINOIN; RIFAMPICIN;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; EPIDERMOID CYST; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCAR; SKIN DEFECT; SKIN HYPERTROPHY; SKIN ULCER; SUPPURATIVE HIDRADENITIS;

ACNE VULGARIS; ADULT; BACK; CICATRIX; CLINDAMYCIN; DERMATOLOGIC AGENTS; EPIDERMAL CYST; FACE; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; PILONIDAL SINUS; RIFAMPIN; SKIN ULCER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956341407     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315508     Document Type: Article

References (16)

1. Jansen T, Plewig G: Acne inversa. Int J Dermatol 1998; 37: 96-100.
2. Slade DE, Powell BW, Mortimer PS: Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 2003; 56: 451-461.
3. Cunliffe WJ, Gollnick HPM: Acne Diagnosis and Management. London, Martin Dunitz, 2001, vol 1, p 83.
4. Jemec GB: Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47-56.
5. Chivot M, Pawin H, Beylot C, Chosidow O, Dreno B, Faure M, Poli F, Revuz J, groupe experts acne: Acne scars: epidemiology, physiopathology, clinical features and treatment. Ann Dermatol Venereol 2006; 133: 813-824.
6. Jacob CI, Dover JS, Kaminer MS: Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001; 45: 109-117.
7. Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F, Viallette C, Revuz J: Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment. Dermatology 2009; 218: 134-135.
8. Jemec GB: Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999; 41: 658.
9. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S: Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of consecutive patients. Dermatology 2009; 219: 148-514.
10. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S: Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009; 61: 51-57.
11. Poli F, Jemec GB, Revuz J: Clinical presentation; in Jemec GBE, Revuz J, Leyden JJ (eds): Hidradenitis Suppurativa. Berlin, Springer, 2006.
12. Lee RA, Yoon A, Kist J: Hidradenitis suppurativa: an update. Adv Dermatol 2007; 23: 289-306.
13. Attanoos RL, Appleton MA, Douglas-Jones AG: The pathogenesis of hidradenitis suppurativa: a closer look at apoeccrine and apocrine glands. Br J Dermatol 1995; 133: 254-258.
14. Jemec GB, Hansen U: Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996; 34: 994-999.
15. Sion-Vardy N, Osyntsov L, Cagnano E, Osyntsov A, Vardy D, Benharroch D: Unexpected location of pilonidal sinuses. Clin Exp Dermatol 2009; 34:e599-e601.
16. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji- Garin S: Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 59: 596-601.